<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03499210</url>
  </required_header>
  <id_info>
    <org_study_id>CLN0011</org_study_id>
    <nct_id>NCT03499210</nct_id>
  </id_info>
  <brief_title>Safety Evaluation of the ReWalk ReStore Device in Subjects With Mobility Impairments Due to Stroke</brief_title>
  <official_title>A Multi-site, Interventional, Non-comparative, Single-arm Trial to Evaluate the Safety of the ReWalk ReStore Device in Subjects With Mobility Impairments Due to Ischemic or Hemorrhagic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ReWalk Robotics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shirley Ryan AbilityLab</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kessler Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TIRR Memorial Hermann</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Moss Rehabilitation Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ReWalk Robotics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-site, interventional, non-comparative, single-arm trial to evaluate the safety of the
      ReWalk ReStore device in subjects with hemiplegia/hemiparesis due to ischemic or hemorrhagic
      stroke.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2018</start_date>
  <completion_date type="Anticipated">August 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of device-related adverse events [Safety]</measure>
    <time_frame>duration of study participation for each subject, estimated 4 weeks</time_frame>
    <description>Safety will be evaluated on the basis of the number of device-related adverse events reported for subjects during their participation in the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of device malfunctions during study procedures [Device Reliability]</measure>
    <time_frame>duration of study completion for each site, estimated 4 months</time_frame>
    <description>Device reliability will be evaluated on the basis of the number of device malfunctions reported by research study staff for the duration of study procedures at each study site.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of injury to physical therapist caused by device [PT safety]</measure>
    <time_frame>duration of study completion for each site, estimated 4 months</time_frame>
    <description>PT safety will be evaluated on the basis of the number of device-related injuries reported by study physical therapists for the duration of study procedures at each study site.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Gait speed measured with 10 Meter Walk Test</measure>
    <time_frame>duration of study participation for each subject, estimated 4 weeks</time_frame>
    <description>Subjects will perform a 10 Meter Walk Test to evaluate walking speed with and without the ReStore device.</description>
  </other_outcome>
  <other_outcome>
    <measure>Gait analysis using a gait mat</measure>
    <time_frame>duration of study participation for each subject, estimated 4 weeks</time_frame>
    <description>Subjects will walk across a gait mat device (such as GAITRite) which records step timing and step placement in order to evaluate their walking with and without the ReStore device.</description>
  </other_outcome>
  <other_outcome>
    <measure>Walking distance measured with 2 Minute Walk Test</measure>
    <time_frame>duration of study participation for each subject, estimated 4 weeks</time_frame>
    <description>Subjects will perform a 2 Minute Walk Test (2MWT) to evaluate the 2 minute walking distance with the ReStore device in Slack, Assist, and Brace modes</description>
  </other_outcome>
  <other_outcome>
    <measure>Modified QUEST questionnaire [subject satisfaction]</measure>
    <time_frame>duration of study participation for each subject, estimated 4 weeks</time_frame>
    <description>Subjects will complete a modified QUEST questionnaire (Quebec User Evaluation of Assistive Technology) to indicate their level of satisfaction with the ReStore device (on a scale from 1 to 5) in 8 different categories.</description>
  </other_outcome>
  <other_outcome>
    <measure>Physical Therapist satisfaction questionnaire [PT satisfaction]</measure>
    <time_frame>duration of study completion for each site, estimated 4 months</time_frame>
    <description>Physical Therapists involved in the study will complete a PT satisfaction questionnaire at the end of the study to indicate their level of satisfaction (on a scale from 1 to 5) with the ReStore device in 9 different categories.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Stroke</condition>
  <condition>Stroke, Acute</condition>
  <condition>Stroke Hemorrhagic</condition>
  <condition>Hemiparesis</condition>
  <condition>Hemiplegia</condition>
  <condition>Cerebrovascular Accident</condition>
  <arm_group>
    <arm_group_label>Investigational group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will participate in study procedures involving use of the ReWalk ReStore device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReWalk ReStore device</intervention_name>
    <description>The ReWalk ReStore device is intended to be used to perform ambulatory functions in rehabilitation institutions under the supervision of a trained therapist for people with hemiplegia/hemiparesis due to stroke.</description>
    <arm_group_label>Investigational group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of one-sided ischemic or hemorrhagic stroke (&gt;2 weeks post stroke)

          -  Presentation of hemiparesis/hemiplegia resulting from stroke

          -  At least 18 years of age

          -  Height of 4'8&quot; - 6'7&quot;

          -  Weight of less than 264 lbs

          -  Medical clearance by a clinician treating the subject

          -  Able to ambulate at least 5 feet without an ankle foot orthosis (AFO), with no more
             than minimal contact assistance from a PT

          -  Able to follow a 3-step command

          -  Able to fit suit components (waistbelt, calf wrap)

          -  No greater than 5 degrees of plantar flexion contracture during passive ankle ROM

          -  Modified Ashworth Scale for spasticity at 3 or less for ankle dorsi-flexors and
             plantar-flexors

        Exclusion Criteria:

          -  Severe aphasia limiting ability to express needs or discomfort verbally or
             non-verbally

          -  Serious co-morbidities that, in the opinion of the investigator, may interfere with
             ability to participate

          -  History of significant Peripheral Artery Disease

          -  Colostomy bag

          -  Current pregnancy

          -  Uncontrolled or untreated hypertension

          -  Currently participating in any other ongoing clinical trial

          -  Presence of open wounds or broken skin at device locations requiring medical
             management

          -  Known urethane allergies

          -  Current medical diagnosis of DVT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kathleen E O'Donnell, MID</last_name>
    <phone>508-251-1154</phone>
    <phone_ext>270</phone_ext>
    <email>kathleen@rewalk.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shirley Ryan AbilityLab</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Spaulding Rehabilitation Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reginia Sloutsky, DPT</last_name>
      <email>gaitlab@bu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kessler Foundation</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Moss Rehab</name>
      <address>
        <city>Elkins Park</city>
        <state>Pennsylvania</state>
        <zip>19027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>TIRR Memorial Hermann</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2018</study_first_submitted>
  <study_first_submitted_qc>April 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Exoskeleton</keyword>
  <keyword>Hemiparesis</keyword>
  <keyword>Hemiplegia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Paresis</mesh_term>
    <mesh_term>Hemiplegia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

